Budapest, Hungary

István Nándor Antal

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Other. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: István Nándor Antal. Retrieved from https://idiyas.com/inventor/istvan-nandor-antal

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of István Nándor Antal

Introduction

István Nándor Antal is a notable inventor based in Budapest, Hungary. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to drug delivery systems. His work focuses on enhancing the effectiveness of medications through advanced formulations.

Latest Patents

Antal holds a patent for a pH-dependent gradual release pharmaceutical composition. This invention addresses the need for a sustained release mechanism that increases the pH in the upper part of the small intestines. The composition features particles coated with a multilayer polymer structure, which ensures the gradual release of the active agent within a specific pH range of 4.5 to 5.5. Additionally, the patent includes a process for preparing this composition, showcasing his commitment to advancing pharmaceutical technology.

Career Highlights

Throughout his career, István Nándor Antal has demonstrated a strong dedication to research and innovation. His work has not only contributed to the scientific community but has also paved the way for improved therapeutic options for patients. His patent reflects his expertise and understanding of complex pharmaceutical challenges.

Collaborations

Antal has collaborated with esteemed colleagues, including Péter Hajnal and Péter Szegó. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the development of innovative solutions in the pharmaceutical industry.

Conclusion

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…